Zeke Capital Advisors’s Labcorp LH Stock Holding History

Zeke Capital Advisors’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$264K	Sell	1,303 -245	-16%	-$47.9K	0.02%	370
2022 Q3	$272K	Sell	1,548 -321	-17%	-$65.7K	0.02%	337
2022 Q2	$376K	Buy	1,869 +236	+14%	+$50.3K	0.03%	265
2022 Q1	$370K	Buy	+1,633	New	+$384K	0.02%	306
2020 Q1	–	Sell	-3,861	Closed	-$561K	–	393
2019 Q4	$561K	Buy	3,861 +448	+13%	+$64.7K	0.05%	352
2019 Q3	$493K	Sell	3,413 -793	-19%	-$116K	0.04%	358
2019 Q2	$625K	Hold	4,206	–	–	0.06%	299
2019 Q1	$553K	Buy	4,206 +794	+23%	+$97.8K	0.05%	331
2018 Q4	$370K	Sell	3,412 -510	-13%	-$68.3K	0.04%	395
2018 Q3	$585K	Hold	3,922	–	–	0.05%	366
2018 Q2	$605K	Hold	3,922	–	–	0.06%	268
2018 Q1	$545K	Hold	3,922	–	–	0.05%	313
2017 Q4	$537K	Buy	+3,922	New	+$518K	0.06%	281

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Zeke Capital Advisors's LH Position: Q4 2022 in Review

Zeke Capital Advisors reduced its Labcorp (LH) stake by 16% in Q4 2022, selling an estimated $47.9K and leaving 1,303 shares worth $264K. The position accounts for 0.02% of the portfolio, ranked #370.

Zeke Capital Advisors first reported a position in LH in Q4 2017 and has held it in 13 quarters since. The position peaked at $625K in Q2 2019. 970 funds tracked by Wall St. Rank hold LH as of Q4 2022.

Zeke Capital Advisors held 1,303 shares of Labcorp worth $264K as of Q4 2022.
Zeke Capital Advisors sold 245 Labcorp shares in Q4 2022, an estimated $47.9K.
Labcorp made up 0.02% of Zeke Capital Advisors's portfolio in Q4 2022, its #370 holding.
Zeke Capital Advisors first reported a position in Labcorp in Q4 2017 and has held it in 13 quarters since.
Zeke Capital Advisors's Labcorp position peaked at $625K in Q2 2019.
970 funds tracked by Wall St. Rank held Labcorp as of Q4 2022.

Based on Zeke Capital Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.